Valuation: Acarix AB

Market Cap 300M 31.12M 27.2M 25.14M 23.23M 43.74M 2.99B 44.54M 118M 1.46B 117M 114M 5.04B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 300M 31.12M 27.2M 25.14M 23.23M 43.74M 2.99B 44.54M 118M 1.46B 117M 114M 5.04B EV / Sales 2026 *
15.7x
EV / Sales 2027 * 4.31x
Free-Float
80.16%
Yield 2026 *
-
Yield 2027 * -
1 day-6.47%
1 week-6.81%
Current month-10.03%
1 month-5.45%
3 months-34.01%
6 months-16.13%
Current year-14.75%
1 week 0.03
Extreme 0.026
0.03
1 month 0.03
Extreme 0.026
0.03
Current year 0.02
Extreme 0.0234
0.04
1 year 0.02
Extreme 0.0234
0.04
3 years 0.01
Extreme 0.009
0.07
5 years 0.01
Extreme 0.009
0.07
10 years 0.01
Extreme 0.009
0.07
Manager TitleAgeSince
Chief Executive Officer - 31/01/2024
Chief Executive Officer 62 22/02/2018
Director TitleAgeSince
Director/Board Member 61 31/12/2019
Director/Board Member 52 13/05/2024
Director/Board Member - 13/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-6.47%-6.81% - - 31.12M
0.00%+12.80%+17.77%-19.24% 17.72B
-0.94%-1.15%+12.91%+90.95% 1.64B
-1.29%+3.88%-38.81%-79.33% 1.2B
-0.83%-6.67%-36.39%+14.83% 1.03B
+3.56%+3.76%-28.27%-53.16% 638M
+0.65%+1.01%-38.78%-55.58% 558M
-2.13%-0.75%+33.29%-54.06% 445M
-0.16%-0.32%-54.66%-59.32% 378M
+0.52%+1.21%-26.02%-28.09% 333M
Average -0.72%+1.04%-17.66%-27.00% 2.66B
Weighted average by Cap. -0.10%+5.77%+8.25%-16.42%

Financials

2026 *2027 *
Net sales 19.1M 1.98M 1.73M 1.6M 1.48M 2.79M 190M 2.84M 7.49M 93.25M 7.45M 7.28M 321M 69.5M 7.21M 6.3M 5.83M 5.38M 10.14M 693M 10.32M 27.27M 339M 27.1M 26.5M 1.17B
Net income -28.9M -3M -2.62M -2.42M -2.24M -4.22M -288M -4.29M -11.34M -141M -11.27M -11.02M -486M 2.4M 249K 218K 201K 186K 350K 23.93M 356K 942K 11.72M 936K 915K 40.34M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change Volume
13/07/26 US$0.0260 -6.47% 20,000

Quarterly revenue - Rate of surprise